Clear answers before you reserve your visit
This comprehensive analysis examines the clinical trial evidence for AOD-9604s safety profile, including participant numbers, study designs, reported adverse effects, metabolic safety markers, immunogenicity data, and how this peptides safety characteristics compare to related therapies
Fate of cobalamins in humans following oral and intramuscular administration of cyanocobalamin, hydroxocobalamin, adenosyl-cobalamin and methylcobalamin
The peptide has been extensively studied in both preclinical models and human clinical trials, demonstrating consistent fat-reducing effects with a favorable safety profile
Notable recent developments include the first preclinical study demonstrating NNMT inhibition improves cardiac function and reduces fibrosis in a heart failure model (Li et al., 2025), a comprehensive review of NNMT as a therapeutic target for neurodegenerative disorders (Liu et al., 2025), and emerging evidence that NNMT inhibition counteracts tubular senescence and fibrosis in chronic kidney disease
[7] [4] If you experience any unexpected or concerning symptoms following injection, err on the side of caution and seek medical advice promptly
